Stock Price Target in Spotlight: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) – The Clayton Caller

This post was originally published on this site

Stock Price Target in Spotlight: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)  The Clayton Caller

Sell-side analysts are offering a consensus “Buy” rating on shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Using the following ratings.

This post was originally published on *this site*